Lutein & Zeaxanthin for AMD progression (at-risk)

Evidence grade B — AREDS2

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade B — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

Outcome	Grade	Effect size	Agreement
AMD progression (at-risk)AREDS2	Evidence grade B	Moderate	high

For amd progression (at-risk), Lutein & Zeaxanthin earns evidence grade B (moderate effect, high consistency) — there is real evidence here. AREDS2

They form macular pigment that filters blue light and quenches oxidative stress in the retina.

10 mg lutein + 2 mg zeaxanthin/day (the AREDS2 amounts), with fat.

Very safe.

Genuinely evidence-based for at-risk eyes (AREDS2). 10 mg lutein + 2 mg zeaxanthin with a meal.

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Entries that share this one's tags or conditions.

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised Jul 10, 2026. A grade is this entry's reading of the evidence, not medical advice.